Successful use of extracorporeal membrane oxygenation for respiratory failure in pulmonary chronic graft-versus-host disease

ASAIO J. 2014 Jan-Feb;60(1):122-3. doi: 10.1097/MAT.0000000000000016.

Abstract

Pulmonary complications of hematopoietic stem cell transplantation (HSCT) are responsible for significant morbidity and mortality. There is no literature to date on the use of extracorporeal membranous oxygenation (ECMO) in patients with pulmonary manifestations of chronic graft-versus-host disease after HSCT. We describe the successful use of ECMO for refractory respiratory failure in such a patient.

Publication types

  • Case Reports

MeSH terms

  • Chronic Disease
  • Extracorporeal Membrane Oxygenation*
  • Graft vs Host Disease / complications*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / surgery*
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy*
  • Treatment Outcome